- Home
- Supplements
- Magnesium
- Arrhythmia
Magnesium for Arrhythmia
Magnesium is legitimately antiarrhythmic when levels are low — hospital IV magnesium is standard care for torsades and perioperative atrial fibrillation prevention. For oral supplementation in people with normal levels, evidence for suppressing ectopy or AF is inconsistent. Fix deficiency; do not expect more.
Overview
Verdict
Essential when low, unproven when normal. Test-guided repletion is evidence-based; blanket supplementation for palpitations is not.
How It Works
Dosing & Protocol
Typical dose
- Recommended dose
- 200–400 mg elemental magnesium daily (glycinate or citrate) if intake is low or deficiency documented
- Expected timeframe
- 2–4 weeks for repletion
Protocol
- form
- Magnesium taurate or glycinate
- duration
- 8-12 weeks with medical review
- co factor
- Correct potassium at the same time - magnesium depletion causes refractory hypokalaemia. Intravenous magnesium in hospital is a different intervention from oral supplementation.
- titration
- Increase to 400 mg if serum magnesium is low-normal and stools are normal
- starting dose
- 200-300 mg elemental magnesium daily with food, only after discussing with the treating clinician
Evidence
What the studies say
Magnesium, Calcium, Potassium, Sodium, Phosphorus, Selenium, Zinc, and Chromium Levels in Alcohol Use Disorder: A Review
Baj J
Such knowledge helps to understand the mechanisms of chronic alcohol-use disorder and to progress and prevent withdrawal effects, also improving treatment strategies.
Magnesium in Prevention and Therapy
Gröber U, Schmidt J, Kisters K
Review of magnesium physiology and therapeutics: deficiency is common and poorly detected by serum levels, and supplementation is used in migraine prophylaxis, eclampsia, arrhythmia, asthma and insulin resistance. Organic salts (citrate, glycinate) show better bioavailability than magnesium oxide.
Intravenous magnesium prevents atrial fibrillation after coronary artery bypass grafting: a meta-analysis of randomized controlled trials
Gu WJ, Wu ZJ, Wang PF
Intravenous magnesium reduced postoperative atrial fibrillation (RR 0.64).
Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study
Khan AM, Lubitz SA, Sullivan LM
Lowest serum magnesium quartile had ~50% higher risk of incident atrial fibrillation.
Safety
Caveats
{"Kidney disease: supplement only under supervision — accumulation is dangerous","High doses cause diarrhea; citrate/glycinate are gentler than oxide","Palpitations with fainting, chest pain, or known heart disease need medical evaluation first","High-dose fish oil, not magnesium, is the supplement actually linked to increased AF risk in trials"}
Less likely to help if
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.